Related references
Note: Only part of the references are listed.Structural studies of influenza virus RNPs by electron microscopy indicate molecular contortions within NP supra-structures
John R. Gallagher et al.
JOURNAL OF STRUCTURAL BIOLOGY (2017)
Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles
Gloria Spagnoli et al.
SCIENTIFIC REPORTS (2017)
Universal influenza virus vaccines and therapeutic antibodies
R. Nachbagauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Edward A. Belongia et al.
LANCET INFECTIOUS DISEASES (2016)
Induction of mucosal immunity through systemic immunization: Phantom or reality?
Fei Su et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
Yuanyuan Li et al.
SCIENTIFIC REPORTS (2016)
Immune signatures of protective spleen memory CD8 T cells
Lilia Brinza et al.
SCIENTIFIC REPORTS (2016)
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza
Andrew C. Hayward et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target
Mustafeez Mujtaba Babar et al.
INFECTION GENETICS AND EVOLUTION (2015)
Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages
Heather M. Machkovech et al.
JOURNAL OF VIROLOGY (2015)
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
Zhongfang Wang et al.
NATURE COMMUNICATIONS (2015)
H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
Hang Xie et al.
SCIENTIFIC REPORTS (2015)
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season
Benjamin S. Chambers et al.
CELL REPORTS (2015)
Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant
Mei Zheng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
Annett Hessel et al.
PLOS ONE (2014)
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
Andrea C. Tricco et al.
BMC MEDICINE (2013)
Nudeoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses
Emma Grant et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Advances in the development of universal influenza vaccines
Sarah C. Gilbert
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein
Thomas Hofmeyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
Teresa Lambe et al.
SCIENTIFIC REPORTS (2013)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
Tom M. Wilkinson et al.
NATURE MEDICINE (2012)
Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
Alexandra J. Spencer et al.
PLOS ONE (2012)
T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein
Emily K. Forbes et al.
PLOS ONE (2012)
T-Cell Responses in Children to Internal Influenza Antigens, 1 Year After Immunization With Pandemic H1N1 Influenza Vaccine, and Response to Revaccination With Seasonal Trivalent-inactivated Influenza Vaccine
Teresa Lambe et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
Baoying Huang et al.
VIROLOGY JOURNAL (2012)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines
Marine L. B. Hillaire et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
CpG Promotes Cross-Presentation of Dead Cell-Associated Antigens by Pre-CD8α+ Dendritic Dells
Christelle de Brito et al.
JOURNAL OF IMMUNOLOGY (2011)
Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance
Mark W. LaMere et al.
JOURNAL OF VIROLOGY (2011)
Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals
Chao Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein
Lina Guo et al.
ARCHIVES OF VIROLOGY (2010)
Immune responses to coiled coil supramolecular biomaterials
Jai S. Rudra et al.
BIOMATERIALS (2010)
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children
Vytautas Usonis et al.
BMC INFECTIOUS DISEASES (2010)
Cross-protective immunity to influenza A viruses
Suzanne L. Epstein et al.
EXPERT REVIEW OF VACCINES (2010)
Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
Rogier Bodewes et al.
PLOS ONE (2009)
MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
Joost H. C. M. Kreijtz et al.
PLOS ONE (2009)
The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria
Solabomi A. Ogun et al.
INFECTION AND IMMUNITY (2008)
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice
Mengcheng Luo et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
BLD cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms
Javier Rangel-Moreno et al.
JOURNAL OF IMMUNOLOGY (2008)
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant
I. Mbawuike et al.
VACCINE (2007)
Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection
Virginia Garcia-Canas et al.
ANALYTICAL CHEMISTRY (2007)
The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA
Qiaozhen Ye et al.
NATURE (2006)
Cell-mediated protection in influenza infection
PG Thomas et al.
EMERGING INFECTIOUS DISEASES (2006)
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature
SL Epstein
JOURNAL OF INFECTIOUS DISEASES (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity
CL Hutchings et al.
JOURNAL OF IMMUNOLOGY (2005)
Cutting edge:: Generation of splenic CD8+ and CD8- dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures
SH Naik et al.
JOURNAL OF IMMUNOLOGY (2005)
Share Paper
